• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

J Med Virol High-Coverage SARS-CoV-2 Genome Sequences Acquired by Target Capture Sequencing

tetano

Editor, Senior Moderator
J Med Virol


. 2020 Jun 3.
doi: 10.1002/jmv.26116. Online ahead of print.
High-Coverage SARS-CoV-2 Genome Sequences Acquired by Target Capture Sequencing


Shaoqing Wen[SUP] 1 2 [/SUP], Chang Sun[SUP] 2 [/SUP], Huanying Zheng[SUP] 3 [/SUP], Lingxiang Wang[SUP] 2 [/SUP], Huan Zhang[SUP] 3 [/SUP], Lirong Zou[SUP] 3 [/SUP], Zhe Liu[SUP] 3 [/SUP], Panxin Du[SUP] 2 [/SUP], Xuding Xu[SUP] 2 [/SUP], Lijun Liang[SUP] 3 [/SUP], Xiaofang Peng[SUP] 3 [/SUP], Wei Zhang[SUP] 3 [/SUP], Jie Wu[SUP] 3 [/SUP], Jiyuan Yang[SUP] 2 [/SUP], Bo Lei[SUP] 2 [/SUP], Guangyi Zeng[SUP] 4 [/SUP], Changwen Ke[SUP] 3 [/SUP], Fang Chen[SUP] 4 [/SUP], Xiao Zhang[SUP] 1 5 [/SUP]



Affiliations

Abstract

In this study, we designed a set of SARS-CoV-2 enrichment probes to increase the capacity for sequence-based virus detection and obtain the comprehensive genome sequence at the same time. This universal SARS-CoV-2 enrichment probe set contains 502 120nt ssDNA biotin-labeled probes designed based on all available SARS-CoV-2 viral sequences and it can be used to enrich for SARS-CoV-2 sequences without prior knowledge of type or subtype. Following the CDC health and safety guidelines, marked enrichment was demonstrated in a virus strain sample from a cell culture, three nasopharyngeal swab samples (cycle threshold [Ct] values: 32.36, 36.72, and 38.44) from patients diagnosed with COVID-19 (positive control) and four throat swab samples from patients without COVID-19 (negative controls), respectively. Moreover, based on these high-quality sequences, we discuss the heterozygosity and viral expression during coronavirus replication, and its phylogenetic relationship with other selected high-quality samples from The Genome Variation Map (GVM). Therefore, this universal SARS-CoV-2 enrichment probe system can capture and enrich SARS-CoV-2 viral sequences selectively and effectively in different samples, especially clinical swab samples with a relatively low concentration of viral particles. This article is protected by copyright. All rights reserved.

Keywords: Gene expression; Genetic networks; Genetic variability; Mutation; SARS coronavirus.
 
Back
Top Bottom